Tullow Oil (LON:TLW) has signed Sale and Purchase Agreements (SPAs) with CNOOC and Total (NYSE:TOT) to sell a one third interest to each party of the interests Tullow holds in Exploration Areas 1, 2 and 3A in Uganda. Tullow will retain a one third interest. The terms of the transactions include a total cash consideration payable to Tullow of US$2.9 billion.
SABMiller (LON:SAB) announced that its subsidiary Bavaria S.A. has established a US$1.325 billion bond and commercial paper programme.
Dixons Retail (LON:DXNS) announced that since its last statement in January, consumer confidence across a number of its markets has deteriorated, particularly in the UK & Ireland. The group expects that underlying profit before tax for the financial year to 30 April 2011 will be around £85 million.
Domino’s Pizza (LON:DOM) said that in the 13 weeks to 30 march, system sales rose 11.2 percent to £132.3 million and like for like sales in 608 mature stores increased 4.2 percent.
Xtract Energy (LON:XTR) announced its interim results for the period to 31 December 2010. The company posted a net profit of £0.79 million after posting a US$2.2 million loss a year earlier. The company had cash of £8.78 million, up from £6.87 million at 30 June 2010, while net assets increased from £9.7 million at 30 June to £10.56 million.
Fusion IP (LON:FIP) released its interim results for the period to 31 January 2011. The company reported that revenues and portfolio returns increased 15 percent to £2.09 million.
Silence Therapeutics (LON:SLN) announced that interim data from its ongoing Phase I clinical study of Atu027, the company's lead internal therapeutic candidate, have been accepted for poster presentation at the 2011 American Society of Clinical Oncology (ASCO) annual meeting.
Amphion Innovations (LON:AMP) announced that its wholly owned subsidiary DataTern has agreed further licenses involving two US patents, generating total revenues of US$665,000.
Deltex Medical (LON:DEMG) announced that the National Institute for Health and Clinical Excellence has today published final guidance recommending the Company's CardioQ-ODM system. In its guidance on implementation by the NHS, NICE estimates that its recommendation applies to 837,000 surgical patients each year in the NHS in England alone.
Across the UK as a whole, using NICE's estimated average saving per patient of £1,100 per hospital stay, this represents a potential £1 billion annualised saving.
Firestone Diamonds (LON:FDI) provided an update on its mining operations in Lesotho and Botswana. The company said that production at production plant 1 at the Liqhobong Mine in Lesotho commenced ahead of schedule in February 2011.
Aminex (LON:AEX) reported its preliminary 2010 results. Gross revenues amounted to US$7.1 million compared to US$7.8 million a year ago. The company is currently preparing to spud the Nyuni-2 well in Tanzania, which is expected within two months.
“We are looking forward to a busy period of exploration drilling on both our main licences in Tanzania, together with commercialisation of the Kiliwani North gas discovery in Tanzania and development drilling in Louisiana. With an active programme supported by a strong balance sheet, shareholders can expect news from several different areas of our portfolio,” said chairman Brian Hall.
Ila Group (LON:ILA) announced its interim results for the period to 31 December 2010. Sales soared 375 percent to £646,995, compared to six months to June 2010. Operating losses decreased to £378,818 from £598,752.
Judges Scientific (LON:JDG) announced its results for the year to 31 December. The company posted record basic earnings per share of 45 pence, up from 28 pence a year earlier.
Oxford Advanced Surfaces (LON:OXA) announced its 2010 results. Group revenues to 31 December 2010 amounted to £259,000. Research and development costs increased to £913,000 (2009 £773,000) driven by the additional investment required in both VISARCTM and OntoTM Surface Functionalisation and Cross Linking technologies to make them customer ready for final development and licence.
The company said that it fully expects 2011 to offer commercial validation of these products with newsflow occurring throughout 2011.